Multiple Sclerosis
Clinical Trials
Clinical trial participants help move research forward while gaining access to the latest potential treatments.
'Paracetamol' photo by Henri Koskinen
Multiple Sclerosis (MS) is a chronic autoimmune disease that impacts the body’s central nervous system. It is believed that MS causes the immune system to attack myelin, which insulates the nerves. This can cause inflammation and lesions that can make affect the brain’s ability to send signals throughout the body.
